Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Rory Driscoll

๐Ÿ‘ค Speaker
613 total appearances

Appearances Over Time

Podcast Appearances

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

But you don't know what's going to price.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

You don't know what's going to trade.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

And maybe they don't want liquidity.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

Now, maybe it's a process of starting.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

And over the next one or two years, they perform.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

They grow.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

You grow 20% year on year, whatever it is, 30%.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

And you just, over time, build up your market cap.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

I don't think we can all stay private forever.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

being passed around amongst us, especially if we're not growing at, you know, I mean, the venture cost of capital should be around 30% and the public cost of capital should be around 11.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

There does come a point when you're better off in the public markets.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

And if it's subscale and cheap, let me tell you what will happen.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

People will buy it and they'll make what's called a capital gain.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

I mean, if I have the courage of my convictions, I should go away, look at the wealth fund numbers and say, I believe it's cheap at 1.2, I should buy.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

You're veering on doing the thing you condemned others to do, which is sneering at a $1, $2, and $3 billion outcome, right?

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

It's the low end of the public company market cap, but it's a perfectly good outcome.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

And to be congratulated, to start a company from nothing and get to $1 or $2 billion in value, get it public, have the chance to compound for 5 or 10 years, it's an awesome achievement.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

And you're right.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

We will look back and go, the winners were the ones who got a crazy valuation in 2021, and then were able to get out from under that valuation via a down round, a down IPO, or a down M&A.

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance

The bad ones are the guys who are still sitting there looking at their 21 valuation and thinking that's ever coming back.